Glucotrack, Inc. — Form S-1/A
Filed October 13, 2026 · analyzed by the Registration Agent
S-1/A
▼ Likely negative
significance 72/100
What the filing says
On July 14, 2026, Glucotrack completed a merger with Lokahi Therapeutics, with Lokahi shareholders receiving 90% of combined entity on fully-diluted basis. Company raised ~$7.95M in Bridge Notes (22% OID, 8% interest, 9-month maturity) and secured $50M ELOC with White Lion Capital. Subsequently issued $11.6M in September Notes (22% OID, 8% interest) and $2M in Interim PIPE. Total registered shares represent ~1,825% of current outstanding (2.37M shares); company has $5.4M market cap and ~$156M accumulated deficit with going-concern doubt.
Why this rating
Massive dilution event (1,825% overhang) and going-concern risk dominate. Series of high-cost financings ($7.95M + $11.6M notes at 8%+, $50M ELOC option) suggest acute capital stress. While merger adds Lokahi assets, extreme shareholder dilution, Nasdaq compliance jeopardy, and accumulated $156M losses make this trajectory-altering for existing shareholders despite potential strategic value.
Tradability signal
NO TRADE
No trade: negative news, but this cell's evidence is too weak. Similar past filings (150 in this cell) moved +0.32% in the called direction over 4 hrs; shrunk for sample size that's a +0.27% edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
at our read · unknown $1.09 | +10 min · unknown $1.09 ▼ 0.28% | +30 min · unknown $1.05 ▼ 3.49% | +1 hr · unknown $1.02 ▼ 6.51% | +4 hrs · unknown $0.86 ▼ 20.83% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.